We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-3.03%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$8.84B
AUM Growth
-$870M
Cap. Flow
-$334M
Cap. Flow %
-3.78%
Top 10 Hldgs %
9.41%
Holding
997
New
62
Increased
315
Reduced
362
Closed
68

Top Buys

Rank Stock Value
1
KD icon
Kyndryl
KD
+$22.1M
2
CRI icon
Carter's
CRI
+$21.6M
3
ENOV icon
Enovis
ENOV
+$19.7M
4
M icon
Macy's
M
+$18.4M
5
SPNS
Sapiens International
SPNS
+$18.3M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$48.8M
2
SPB icon
Spectrum Brands
SPB
+$27.6M
3
HUN icon
Huntsman Corp
HUN
+$22.1M
4
EAF icon
GrafTech
EAF
+$17.5M
5
VNT icon
Vontier
VNT
+$17.5M

Sector Composition

Rank Sector Weight
1 Industrials 27.25%
2 Technology 17.95%
3 Consumer Discretionary 13.92%
4 Financials 13.49%
5 Materials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPR
626
DELISTED
Express, Inc.
EXPR
$1.98M 0.02%
90,823
+1,555
+2% +$53.1K
CSIQ icon
627
Canadian Solar
CSIQ
$932M
$1.97M 0.02%
53,000
RADA
628
DELISTED
Rada Electronic Industries Ltd
RADA
$1.95M 0.02%
+202,910
New +$2.07M
WSFS icon
629
WSFS Financial
WSFS
$4.14B
$1.95M 0.02%
42,004
-12,945
-24% -$605K
MHH icon
630
Mastech Digital
MHH
$95.4M
$1.95M 0.02%
131,655
+41,941
+47% +$635K
ATR icon
631
AptarGroup
ATR
$8.69B
$1.94M 0.02%
20,396
ENSG icon
632
The Ensign Group
ENSG
$10.6B
$1.93M 0.02%
24,306
-1,700
-7% -$141K
NRC icon
633
NRC Health Common Stock
NRC
$405M
$1.93M 0.02%
48,397
+179
+0.4% +$6.63K
MAG
634
DELISTED
MAG Silver
MAG
$1.92M 0.02%
154,050
SSYS icon
635
Stratasys
SSYS
$666M
$1.92M 0.02%
133,000
-21,000
-14% -$374K
BELFA icon
636
Bel Fuse Inc Class A
BELFA
$2.88B
$1.89M 0.02%
67,705
PCTY icon
637
Paylocity
PCTY
$7.75B
$1.88M 0.02%
7,786
COHR icon
638
Coherent
COHR
$43.4B
$1.87M 0.02%
53,756
-25,856
-32% -$1.24M
WWE
639
DELISTED
World Wrestling Entertainment
WWE
$1.86M 0.02%
26,571
-24,167
-48% -$1.65M
GPI icon
640
Group 1 Automotive
GPI
$4.26B
$1.84M 0.02%
12,879
+3,166
+33% +$543K
UPLD icon
641
Upland Software
UPLD
$13.3M
$1.84M 0.02%
22,596
+490
+2% +$54.2K
FBC
642
DELISTED
Flagstar Bancorp, Inc. New
FBC
$1.82M 0.02%
54,592
+4,190
+8% +$160K
FC icon
643
Franklin Covey
FC
$239M
$1.82M 0.02%
40,100
PROF
644
Profound Medical
PROF
$263M
$1.8M 0.02%
444,898
-58,000
-12% -$391K
GLDD
645
DELISTED
Great Lakes Dredge & Dock
GLDD
$1.77M 0.02%
233,034
-352,497
-60% -$3.69M
ENVX icon
646
Enovix
ENVX
$803M
$1.76M 0.02%
109,714
+18,285
+20% +$270K
PFIE
647
DELISTED
Profire Energy, Inc
PFIE
$1.75M 0.02%
2,062,061
GROW icon
648
US Global Investors
GROW
$36.3M
$1.74M 0.02%
604,954
PGNY icon
649
Progyny
PGNY
$2.46B
$1.71M 0.02%
46,000
CLAR icon
650
Clarus
CLAR
$125M
$1.7M 0.02%
126,503

Similar funds

Royce & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Royce & Associates held 997 positions worth $8.84B, down 9% from $9.71B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Royce & Associates withdrew a net $334M in Q3 2022, closing 68 positions and reducing 362 holdings. Its most notable exit was Avalara, Inc., an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Kyndryl worth $17.6M.

  • Royce & Associates's largest Q3 2022 buy was Kyndryl: 2,126,158 shares worth $17.6M.
  • Royce & Associates added most to Carter's in Q3 2022, an estimated $21.6M increase.
  • Royce & Associates's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $48.8M.
  • Royce & Associates fully exited Avalara, Inc. in Q3 2022, selling an estimated $17.4M.
  • Royce & Associates's ten largest holdings make up 9.4% of its $8.84B portfolio in Q3 2022.
  • Royce & Associates opened 62 new positions and closed 68 in Q3 2022.
  • Royce & Associates's portfolio value fell 9% quarter-over-quarter to $8.84B.

Based on Royce & Associates's 13F filing for Q3 2022, filed 3 Nov 2022.